These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 17086129

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Treatment of NMO].
    Saida T.
    Rinsho Shinkeigaku; 2009 Nov; 49(11):902-5. PubMed ID: 20030244
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Neuromyelitis optica immunoglobulins as a marker of disease activity and response to therapy in patients with neuromyelitis optica.
    Weinstock-Guttman B, Miller C, Yeh E, Stosic M, Umhauer M, Batra N, Munschauer F, Zivadinov R, Ramanathan M.
    Mult Scler; 2008 Sep; 14(8):1061-7. PubMed ID: 18573816
    [Abstract] [Full Text] [Related]

  • 8. Treatment of neuromyelitis optica: an evidence based review.
    Sato D, Callegaro D, Lana-Peixoto MA, Fujihara K, Brazilian Committee for Treatment and Research in Multiple Sclerosis.
    Arq Neuropsiquiatr; 2012 Jan; 70(1):59-66. PubMed ID: 22218475
    [Abstract] [Full Text] [Related]

  • 9. [Diagnosis and treatment of neuromyelitis optica].
    Nielsen HH, Ravnborg M, Illes Z.
    Ugeskr Laeger; 2014 Jun 23; 176(26):V02130104. PubMed ID: 25294570
    [Abstract] [Full Text] [Related]

  • 10. Devic syndrome: can antiphospholipid antibodies be a factor?
    Foroughipour M, Nikbin Z, Sahebari M, Pezeshki Rad M, Shoeibi A.
    J Clin Rheumatol; 2012 Dec 23; 18(8):419-21. PubMed ID: 23188206
    [No Abstract] [Full Text] [Related]

  • 11. [Treatment of neuromyelitis optica].
    Nomura K.
    Nihon Rinsho; 2013 May 23; 71(5):829-38. PubMed ID: 23777090
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Neuromyelitis optica in children. Two case reports].
    Tosello B, Halbert C, Mancini J, Chabrol B, Boucraut J, Milh M.
    Arch Pediatr; 2012 Aug 23; 19(8):827-31. PubMed ID: 22789744
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Encephalopathy and neuromyelitis optica: the importance of recognising atypical symptoms].
    Hervás-García JV, Grau-López L, Doménech-Puigcerver S, Ramo-Tello C.
    Rev Neurol; 2014 Jan 01; 58(1):20-4. PubMed ID: 24343537
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome.
    Jarius S, Kleiter I, Ruprecht K, Asgari N, Pitarokoili K, Borisow N, Hümmert MW, Trebst C, Pache F, Winkelmann A, Beume LA, Ringelstein M, Stich O, Aktas O, Korporal-Kuhnke M, Schwarz A, Lukas C, Haas J, Fechner K, Buttmann M, Bellmann-Strobl J, Zimmermann H, Brandt AU, Franciotta D, Schanda K, Paul F, Reindl M, Wildemann B, in cooperation with the Neuromyelitis Optica Study Group (NEMOS).
    J Neuroinflammation; 2016 Nov 01; 13(1):281. PubMed ID: 27802825
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.